Physician profile
Herbert L Isaac
NPI 1841231941
$1,972.99
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $119 · 2021: $368 · 2022: $445 · 2023: $129 · 2024: $73.06 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $367.07 | 2022-2025 | |
| Avanir Pharmaceuticals, INC. | $273.41 | 2019-2021 | |
| Pfizer INC. | $166.71 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $150.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $139.92 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $126.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2022 | |
| Ironshore Pharmaceuticals INC. | $124.99 | 2019 | |
| Neurelis, INC. | $111.51 | 2023 | Valtoco |
| Lilly USA, LLC | $95.31 | 2019 | |
| Kestra Medical Technology Services, INC. | $73.06 | 2024 | Assure Wcd |
| Ucb, INC. | $52.91 | 2019-2021 | |
| Dexcom, INC. | $48.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.45 | 2019 | |
| Glaxosmithkline, LLC. | $29.83 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $28.88 | 2021 | |
| Acadia Pharmaceuticals INC | $17.39 | 2023 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.